Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Many congratulations to Professor Michael Dustin on his election as a member of the European Molecular Biology Organisation (EMBO).

Professor Dustin was one of 65 outstanding life scientists to be elected to its membership, joining a group of more than 1700 of the best researchers in Europe and around the world.

Professor Michael Dustin joins Professor Fiona Powrie and Sir Marc Feldman as EMBO members from the Kennedy Institute of Rheumatology.

EMBO Director Maria Leptin said:

“Election to the EMBO Membership is recognition of research excellence, and I am pleased to welcome so many great scientists to our organisation.”

She continues: “We received more nominations than ever before during this election cycle, which pays tribute to the strength and diversity of the European life sciences. Drawing on our new members’ expertise and insight will be invaluable in helping EMBO to deliver and strengthen its programmes and activities in the years to come.”

Professor Dustin exclaimed:

“It’s an honour to be elected a member of EMBO only a few years after arriving here in the UK. I look forward to contributing to EMBO’s mission in years to come.”

EMBO Members are actively involved in the execution of the organisation’s initiatives by evaluating applications for EMBO funding and by serving on EMBO Council, Committees and Editorial Boards.

An online directory with all existing and new EMBO Members is available at people.embo.org.

Similar stories

Small mechanical forces in immune cells measured at unprecedented sensitivity

Kennedy Main Research

Oxford researchers have used advanced microscopy techniques to measure previously unseen forces generated by cells during an immune response; a breakthrough for mechanobiology and future advances in health and disease.

NDORMS researchers awarded for Dupuytren research

Awards Hand Kennedy Main

Three NDORMS researchers have received awards from the International Dupuytren Society, a patient organisation that brings together Dupuytren Disease patient societies from across the world.

Hope for rheumatoid arthritis patients who are non-responsive to anti-TNF

Arthritis Kennedy Main

New research published in The Lancet shows that tocilizumab is a more effective treatment than rituximab for rheumatoid arthritis patients with a poor response to anti-tumour necrosis factor (TNF).

A new study maps the expression of innate immune receptors during the course of arthritis

Arthritis Kennedy Main

The research, which was a collaboration with researchers from Oxford University and Queen Mary University of London and published in Journal of Autoimmunity, looked at changes in receptors known as toll-like receptors (TLRs) in arthritis at different stages of disease.

International Women's Day

Department Main

It’s International Women's Day! This year’s theme is #Choosetochallenge. We’re celebrating some of the amazing women at NDORMS, and asking them what changes they’d like to see in medical sciences over the next 100 years.

Patients and carers invited to join new group helping to shape research and treatment of bones, muscles and joints

Main PPI

Oxford’s newest patient partner group, OPEN ARMS launches today to explore the causes, treatment and care for patients with musculoskeletal conditions. Its first three patient partners explain why they are involved and invite other members of the public to join the team.